Prostate cancer clinical quality performance indicators: engagement document

Document explaining the process of, and inviting engagement on, revision of the prostate cancer QPIs.

2. Quality Performance Indicator Development Process

The QPI development process was designed to ensure that indicators are developed in an open, transparent and timely way. The development process can be found in appendix 1.

The Prostate Cancer QPI Development Group was convened in October 2010, chaired by Professor Robert Masterton (Executive Medical Director, NHS Ayrshire and Arran). Membership of this group included clinical representatives drawn from the three regional cancer networks, Healthcare Improvement Scotland, ISD and patient/carer representatives. Membership of the development group can be found in appendix 2.


Back to top